MultiSensor AI Holdings, Inc.
For the period ended Sep 30, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 13, 2025
MSAI$3.05-4.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows (unaudited)
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands of U.S. dollars*)*
| | | | | | | |
|---|---|---|---|---|---|---|
| · · Nine months ended | ||||||
| · · September 30, · · September 30, | ||||||
| · · 2025 · · 2024 | ||||||
| Operating Activities · · | ||||||
| Net loss | | $(9,435) | | $(18,510) | ||
| Adjustments to reconcile net loss to net cash: provided by (used in) operating activities | | | | | ||
| Depreciation | | 952 | | 878 | ||
| Inventories impairment | | | — | | | 2,272 |
| Non-cash lease activity | | 108 | | 111 | ||
| Bad debt expenses (recoveries) | | | (1) | | | 42 |
| Deferred income tax (income) expense | | (7) | | 53 | ||
| Share-based compensation | | 1,535 | | 3,355 | ||
| Loss (gain) on disposal of equipment | | | (33) | | | 342 |
| Loss on financing transaction | | — | | 1,381 | ||
| Change in fair value of warrants liabilities | | | — | | | (39) |
| Non-cash equity line of credit commitment fee | | | — | | 500 | |
| Change in fair value of convertible notes | | — | | 475 | ||
| Increase (decrease) in cash resulting from changes in: | | | | | ||
| Trade accounts receivable | | 79 | | 1,613 | ||
| Inventories | | 51 | | 102 | ||
| Other current assets | | 391 | | 1,766 | ||
| Other noncurrent assets | | | (55) | | | — |
| Trade accounts payable | | (47) | | (1,870) | ||
| Income taxes payable | | (57) | | (820) | ||
| Income tax receivable | | | — | | | (413) |
| Contract liabilities | | 1,192 | | (1,251) | ||
| Other current liabilities | | (114) | | 172 | ||
| Right of use liabilities | | (110) | | (121) | ||
| Accrued expenses | | (279) | | (2,522) | ||
| Contract liabilities, noncurrent | | | 47 | | | (26) |
| Net cash provided by (used in) operating activities | | $(5,783) | | $(12,510) | ||
| Investing Activities | | | | | ||
| Capital expenditures | | (1,268) | | (1,600) | ||
| Proceeds from sale of equipment | | | 24 | | | — |
| Net cash provided by (used in) investing activities | | $(1,244) | | $(1,600) | ||
| Financing Activities | | | | | ||
| Proceeds from issuances of common stock | | | 4,773 | | | 22,785 |
| Repayment of promissory notes | | | (172) | | | (575) |
| Tax payments associated with share-based compensation transactions | | | (918) | | | — |
| Repayments of lines of credit | | | — | | | (622) |
| Net cash provided by (used in) financing activities | | $3,683 | | $21,588 | ||
| Net increase/(decrease) in cash, cash equivalents, and restricted cash equivalents | | (3,344) | | 7,478 | ||
| Cash, cash equivalents, and restricted cash equivalents beginning of period | | 4,508 | | 1,155 | ||
| Cash, cash equivalents, and restricted cash equivalents end of the period | | $1,164 | | $8,633 | ||
| | | | | | | |
| Reconciliation of cash, cash equivalents and restricted cash equivalents at end of period | | | | | | |
| Cash and cash equivalents | | $1,064 | | $8,633 | ||
| Restricted cash equivalents included in other current assets | | | 100 | | | — |
| Cash, cash equivalents, and restricted cash equivalents end of the period | | $1,164 | | $8,633 | ||
| | | | | | | |
| Supplemental cash flow information | | | | | ||
| Interest paid | | $— | | $63 | ||
| Income tax paid, net of refunds received | | 110 | | 2,331 | ||
| | | | | | | |
| Non-cash investing and financing transactions | | | | | | |
| Settlement of vendor liability with share issuance | | $36 | | | — | |
| Conversion of convertible notes | | | — | | $6,170 | |
| Conversion of Legacy SMAP promissory loan into common stock | | | — | | | 200 |
| Shares issued for Equity Line of Credit commitment fee | | | — | | | 500 |
| Inducement shares from Financing Transaction | | | — | | | 1,381 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.